# IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types

> **NCT04285996** · NA · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 19 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** PET Scan

## Key facts

- **NCT ID:** NCT04285996
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-17
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-15
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285996, "IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04285996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*